{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:07:59Z","timestamp":1794917279849,"version":"4.9.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Anti-NOR90 antibodies are usually found in patients with SSc; however, their clinical relevance remains obscure. We developed an ELISA for measuring them to investigate the clinical features of patients with anti-NOR90 antibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples from 1252 patients with various conditions from Nagoya University Hospital and 244 patients with idiopathic interstitial pneumonia (IIP) from Tosei General Hospital were included. Anti-NOR90 antibodies were assayed by an ELISA using the recombinant protein produced by in vitro transcription\/translation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five (0.4%) patients in the Nagoya University Hospital cohort had anti-NOR90 antibodies. One patient with diffuse cutaneous SSc, three with limited cutaneous SSc, and one with Raynaud\u2019s disease were positive for anti-NOR90 antibodies. Anti-NOR90 antibodies were found more frequently in patients with systemic scleroderma-spectrum disorders (SSDs) than without SSDs (5\/316 vs 0\/936, P &amp;lt;0.00101) and were found more frequently in patients with SSc than without SSc (4\/249 vs 0\/528, P &amp;lt;0.0104) in the systemic autoimmune rheumatic diseases cohort. Three of the four anti-NOR90-positive SSc patients had interstitial lung disease (ILD), and two of those four had cancer. Three (1.2%) patients in the Tosei General Hospital cohort had anti-NOR90 antibodies. All three of the anti-NOR90-positive IIP patients had gastrointestinal tract involvement, and two of those three had cancer or skin lesions observed in SSc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although anti-NOR90 antibodies are rarely found in clinics, our ELISA is useful for their detection. Further studies are needed to confirm the association of anti-NOR90 antibodies with ILD and cancer in SSc and IIP patients.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keab575","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T19:11:05Z","timestamp":1626462665000},"page":"1709-1716","source":"Crossref","is-referenced-by-count":20,"title":["Clinical significance of anti-NOR90 antibodies in systemic sclerosis and idiopathic interstitial pneumonia"],"prefix":"10.1093","volume":"61","author":[{"given":"Yuta","family":"Yamashita","sequence":"first","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Muro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Ogawa-Momohara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Takeichi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kondoh","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"2022041112505127300_keab575-B1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J Dermatol"},{"key":"2022041112505127300_keab575-B2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2022041112505127300_keab575-B3","first-page":"1543","article-title":"Autoantibodies to NOR 90\/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response","volume":"29","author":"Dagher","year":"2002","journal-title":"J Rheumatol"},{"key":"2022041112505127300_keab575-B4","first-page":"859","article-title":"Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies","volume":"140","author":"Imai","year":"1992","journal-title":"Am J Pathol"},{"key":"2022041112505127300_keab575-B5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1084\/jem.174.5.1239","article-title":"Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor","volume":"174","author":"Chan","year":"1991","journal-title":"J Exp Med"},{"key":"2022041112505127300_keab575-B6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","article-title":"Disease-related autoantibody profile in patients with systemic sclerosis","volume":"50","author":"Liaskos","year":"2017","journal-title":"Autoimmunity"},{"key":"2022041112505127300_keab575-B7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fmed.2019.00209","article-title":"Interstitial pneumonia with autoimmune features (IPAF)","volume":"6","author":"Fernandes","year":"2019","journal-title":"Front Med"},{"key":"2022041112505127300_keab575-B8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.22551","article-title":"The Pediatric Rheumatology European Society\/American College of Rheumatology\/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis","volume":"57","author":"Zulian","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022041112505127300_keab575-B9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022041112505127300_keab575-B10","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022041112505127300_keab575-B11","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2022041112505127300_keab575-B12","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.rmed.2011.03.022","article-title":"Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias","volume":"105","author":"Watanabe","year":"2011","journal-title":"Respir Med"},{"key":"2022041112505127300_keab575-B13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.20096","article-title":"Anti-DFS70 antibodies in 597 healthy hospital workers","volume":"50","author":"Watanabe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022041112505127300_keab575-B14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaut.2004.07.003","article-title":"Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain","volume":"23","author":"Ogawa","year":"2004","journal-title":"J Autoimmun"},{"key":"2022041112505127300_keab575-B15","doi-asserted-by":"crossref","first-page":"856815","DOI":"10.1155\/2013\/856815","article-title":"A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement","volume":"2013","author":"Muro","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2022041112505127300_keab575-B16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13075-015-0573-x","article-title":"Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma","volume":"17","author":"Muro","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2022041112505127300_keab575-B17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022041112505127300_keab575-B18","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.139.8.2579","article-title":"Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin","volume":"139","author":"Rodriguez-Sanchez","year":"1987","journal-title":"J Immunol"},{"key":"2022041112505127300_keab575-B19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.1780390808","article-title":"Detection of autoantibodies to nucleolar transcription factor NOR 90\/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays","volume":"39","author":"Fujii","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2022041112505127300_keab575-B20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00997157","article-title":"Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90\/hUBF autoantigens","volume":"19","author":"Imai","year":"1994","journal-title":"Mol Biol Rep"},{"key":"2022041112505127300_keab575-B21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1962.03050210027006","article-title":"Progressive systemic sclerosis sine scleroderma","volume":"180","author":"Rodnan","year":"1962","journal-title":"JAMA"},{"key":"2022041112505127300_keab575-B22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G","article-title":"Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients","volume":"43","author":"Poormoghim","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022041112505127300_keab575-B23","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2022041112505127300_keab575-B24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.41493","article-title":"Cancer in systemic sclerosis: analysis of antibodies against components of the Th\/To complex","volume":"73","author":"Mecoli","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2022041112505127300_keab575-B25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc3496","article-title":"Dysregulation of the basal RNA polymerase transcription apparatus in cancer","volume":"13","author":"Bywater","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2022041112505127300_keab575-B26","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s10067-020-04973-0","article-title":"Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies","volume":"39","author":"Hamaguchi","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2022041112505127300_keab575-B27","first-page":"67","article-title":"Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90)","volume":"22","author":"Dick","year":"1995","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab575\/40426585\/keab575.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1709\/43356130\/keab575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1709\/43356130\/keab575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:15:23Z","timestamp":1672856123000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/4\/1709\/6324309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,7,20]]},"published-print":{"date-parts":[[2022,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab575","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,7,20]]}}}